Potential benefits people commonly report include: However, research involving TB-500 remains limited, especially in human clinical trials
Reported benefits (per available research): Studied in animal (rodent) models for tendon, ligament, and muscle healing, with researchers attributing effects to promotion of angiogenesis and fibroblast activity (preclinical studies from a Croatian research group at the University of Zagreb, spanning several decades) Originally investigated for gastroprotective properties
Its safety profile, combined with its wide range of therapeutic applications, positions it as a strong candidate for replacing BPC-157 in treatment protocols
There is a similar beneficial effect in the rats with the Pringle maneuver, ischemia, reperfusion, and suprahepatic inferior caval vein occlusion (BuddChiari syndrome) (Kolovrat et al., 2020)